Skip to content

Effects of transnasal humidified rapid-insufflation ventilatory exchange and oropharyngeal airway mask ventilation on gastric insufflation during anesthesia induction in patients with OSAS: a randomized controlled clinical trial

Effects of transnasal humidified rapid-insufflation ventilatory exchange and oropharyngeal airway mask ventilation on gastric insufflation during anesthesia induction in patients with OSAS: a randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083976
Enrollment
Unknown
Registered
2024-05-08
Start date
2024-05-15
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric Insufflation

Interventions

THRIVE group:Transnasal humidified rapid insufflation ventilatory exchange was performed during the induction of anesthesia
Oropharyngeal airway mask ventilation group:Oropharyngeal airway mask ventilation was performed during anesthesia induction

Sponsors

Zhejiang Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1: Age =18 years old, =80 years old; 2: STOP-BANG score =3 and BMI =25 kg/m^2; 3: the patient was scheduled for elective surgery with endotracheal intubation under general anesthesia; 4: ASA physical status I-III; 5: Informed consent was obtained from the participants or their family members.

Exclusion criteria

Exclusion criteria: 1: Patients refuse to participate; 2: facial pathology, nasopharyngeal injury or disease; 3: patients with gastric or gastrointestinal decompression tube; 4: The stomach image could not be obtained by ultrasound; 5: ASA grade > ?; 6: patients with respiratory insufficiency, history of obstructive pulmonary disease, history of bronchospasm requiring treatment within 3 months, acute respiratory infection within 1 week, and obvious symptoms such as fever, wheezing, nasal congestion, and cough; 7: pregnant or lactating women; 8: patients who were deemed by the investigator to be ineligible to participate in the trial.

Design outcomes

Primary

MeasureTime frame
Supine CSAa images;

Secondary

MeasureTime frame
Respiratory parameter index;Modified smiling face scale;

Countries

China

Contacts

Public ContactJia Zhe

Zhejiang Cancer Hospital

jiazhehangzhou@163.com+86 157 0010 1597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026